🎉 Celebrating 20 years of @VHIO!
We are incredibly proud to be part of an institution where scientists and clinicians work to turn discoveries into hope for cancer patients.❤️
Here's to the next 20 years of science, collaboration and innovation!
tinyurl.com/mu4fj2zn
LSoucekLab retweeted
🎗️ En el #DíaMundialContraElCáncerDeMama, recuperamos las charlas y talleres para pacientes con #CáncerDeMama, organizadas junto a @ChicEndavant y @vallhebron
💻 Un espacio para abordar los tratamientos y los aspectos físicos, emocionales y sociales de la enfermedad.
▶️ Disponibles en nuestro canal de #YouTube 👉 youtube.com/playlist?list=PL…
#MamaVHIO #VHIODivulga
LSoucekLab retweeted
💬 “Los resultados que creamos aquí en los laboratorios van a poderse pasar rápidamente a los pacientes.”
Iñigo González, investigador postdoctoral del Grupo de Modelización de Terapias Antitumorales, y Jordi Martínez-Quintanilla, investigador sénior del Grupo de Células Madre y Cáncer, reflexionan sobre la colaboración entre grupos, el vínculo con la clínica y el futuro de la investigación traslacional en VHIO.
▶️ Vídeo completo en YouTube
➕ 20anys.vhio.net
#20VHIO @vallhebron @ignigor
📢 Excited to share our latest review in @FrontCellDevBio!
Led by @lvmanu_ with Mariano Zacarías-Fluck and @LauraSoucek, our work discusses how #MYC drives #melanoma progression, plasticity and resistance.
Read it here: frontiersin.org/articles/10.…
@VHIO @icreacommunity @peptomyc
LSoucekLab retweeted
🔬 Our 2025 Scientific Report is now out‼️ Driving progress through disruptive science and clinical innovation in oncology. 🚀
🔗 Read the full report 👉 linke.to/VHIOScientificRepor…
LSoucekLab retweeted
🔝 #VHIO renova l'acreditació com a Centre d'Excel·lència Severo Ochoa, consolidant el nostre lideratge en recerca oncològica i aposta per transformar la ciència en noves oportunitats per als pacients.
👏 Un reconeixement a totes les persones que fan possible el VHIO. Gràcies‼️
➡️ linke.to/ReacreditacionSever…
#SOMMVhio
LSoucekLab retweeted
📣 New VHIO-@CaixaResearch Scientific Seminar‼️
🔹 Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies
👩🔬 @sheilasinghlab, Head of the School of Cancer & Pharmaceutical Sciences and Director of the Comprehensive Cancer Centre @KingsCollegeLon & Professor at @EvelinaLondon @GSTTnhs
🗓 Friday, 19th June at 12h
🎤 Host: @LauraSoucek
Register at 👉 [email protected]
LSoucekLab retweeted
📣 New VHIO-@CaixaResearch Scientific Seminar‼️
🔹 Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies
👩🔬 @sheilasinghlab, Head of the School of Cancer & Pharmaceutical Sciences and Director of the Comprehensive Cancer Centre @KingsCollegeLon & Professor at @EvelinaLondon @GSTTnhs
🗓 Friday, 19th June at 12h
🎤 Host: @LauraSoucek
Register at 👉 [email protected]
LSoucekLab retweeted
For years, #RAS and #MYC were considered "undruggable." The success of RAS has changed the conversation. Proud to see this recent @Nature News & Views highlighting MYC as a promising next frontier and @Peptomyc as a key player helping advance the field. nature.com/articles/d41586-0…
LSoucekLab retweeted
Exciting news for patients and for the oncology community. The Phase 3 #daraxonrasib results in mPDAC show once again that pursuing challenging targets can lead to meaningful clinical advances and that ambitious science is worth the effort.
nejm.org/doi/full/10.1056/NE…
#RASi #MYCi
LSoucekLab retweeted
Enhorabona!
🇪🇺🔬L'@ERC_Research concedeix subvencions a 17 beneficiaris a Catalunya i 1 a les Balears.
Són ajuts a la recerca científica per avaluar el potencial d’innovació en aplicacions comercials i socials en medecina, geologia, bioenginyeria, entre altres.
🔗link.europa.eu/DGckqB
LSoucekLab retweeted
I always try to say yes to student invitations—my small way to feed forward and support the next generation in science.
Huge thanks to the PhD students who organized the event—fantastic job! Despite train delays and a very late return home, it was absolutely worth it 😊
LSoucekLab retweeted
Last Friday I was an invited speaker at the PhD Day of @IIBM_CSIC / CSIC-UAM / CIBERER / IdiPaz in Madrid.
I talked about the journey toward a clinically viable MYC inhibitor and my path as a researcher (@VHIO, @icreacommunity, @LSoucekLab) and entrepreneur (@peptomyc).
New review out in @FrontImmunol! 🎉
We explore how the oncogene MYC drives immune evasion and resistance to cancer immunotherapy—and why targeting MYC could help restore antitumor immunity.
👉 frontiersin.org/journals/imm…
@VHIO @icreacommunity @peptomyc
LSoucekLab retweeted
🗞️Una revisió publicada a @FrontCellDevBio
amb participació de l'#investigadorICREA @LauraSoucek (@VHIO @peptomyc), analitza com la combinació d'inhibidors oncogènics MYC amb teràpies dirigides obre noves oportunitats terapèutiques.
frontiersin.org/journals/cel…
We are hiring! If you are interested in joining our Models of Cancer Therapy Laboratory lab at @VHIO as a Research Laboratory Technician / Lab Manager, apply here: jobs.vhio.net/en/jobs/701839…
LSoucekLab retweeted
🎉 New review in @FrontCellDevBio: #MYC in DNA damage response (#DDR) — driver of genomic instability and DNA repair.
Key idea: #MYC inhibition → DDR vulnerabilities → rational combos (#PARP, ATR/CHK1, WEE1).
🔗 frontiersin.org/journals/cel…
#MYC #DDR @VHIO @peptomyc @icreacommunity
Una vez más ganadores del primer premio en el concurso de decoración navideña del @VHIO! Como siempre, el trabajo en equipo nos encanta :) Go Team!
LSoucekLab retweeted
Ayer @LauraSoucek , nuestra CSO, participó como Keynote Speaker en la 19ª Jornada Científica y 29ª Conferencia Anual del Hospital Vall d’Hebron ✨
Agradecemos al @vallhebron por crear un espacio de intercambio tan enriquecedor.
shorturl.at/Bd8Fl
#MYC #KeynoteSpeaker
